Most Popular News Today

• BioLineRx Class Action Alert: Submit Your Losses to Johnson Fistel

  Jan 5 MicroCapNewsDaily

  January 5, 2023

  The Class Action Seeks to Recover Damages on Shareholders’ Behalf SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces t more...

• Canadian Solar (CSIQ) to Supply 550MWh Energy Storage Products

  Jan 5 MicroCapNewsDaily

  January 5, 2023

  Canadian Solar Inc. CSIQ recently revealed that CSI Energy Storage, part of the company’s CSI Solar subsidiary, has signed a supply agreement with United Kingdom’s (U more...

• Cyclacel Pharmaceuticals Reviews 2022 Achievements and Announces Key Business Objectives for 2023

  Jan 5 MicroCapNewsDaily

  January 5, 2023

  – Determination of Recommended Phase 2 Dose and Start of Phase 2 in 1Q 2023 for Oral Fadraciclib – – 2/3 Partial Responses in Lymphoma and 11/15 Stable Disease in Advanced Solid Tu more...

• CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event

  Jan 5 MicroCapNewsDaily

  January 5, 2023

  CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event PR Newswire Live video webcast on more...

• Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

  Jan 5 MicroCapNewsDaily

  January 5, 2023

  LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical more...

• “Modern Miracles”: ReWalk Technology Showcased at the Hanukkah Celebration Hosted by the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp

  Jan 5 MicroCapNewsDaily

  January 5, 2023

  ReWalk Robotics, Ltd. is honored to have presented its technology at the prestigious Modern Miracles Celebration with the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp. more...

• Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate

  Jan 5 MicroCapNewsDaily

  January 5, 2023

  POSH-MAP and PORT-MAP investigator-sponsored trials to evaluate ability of ACER-801 (osanetant) to reduce hot flashes and as neoadjuvant therapy in men with prostate cancer NEWTON, Mass., Jan more...

• MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

  Jan 5 MicroCapNewsDaily

  January 5, 2023

  Los Angeles, California--(Newsfile Corp. - January 5, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eiger more...